Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Heparin in Burn Patients With Inhalation Trauma
NCT01773083Phase 3Terminated
- Sponsor
- University of Amsterdam
- Start
- Oct 2013
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of heparin in Inhalation injury, sponsored by University of Amsterdam. Started Oct 2013; status: terminated.
02
Drugs
heparin
03
Conditions
Inhalation injury
Beyond the preview
Go deeper on NCT01773083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01773083.